Failure to precondition pathological human myocardium

Journal of the American College of Cardiology

Volumn 37, Issue 3, 2001, Pages 711-718

  Ghosh, Sudip ^a   Standen, Nicholas B ^a   Galiñanes, Manuel ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE; DIAZOXIDE; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN TISSUE; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; REOXYGENATION; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; AGED; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MITOCHONDRIA, HEART; POTASSIUM CHANNELS; SIGNAL TRANSDUCTION;

EID: 0035281710     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01161-X     Document Type: Article

References (34)

1. Myocardial adaptation to ischemia - The preconditioning phenomenon
2. + channel?
3. Ischemic preconditioning in human and rat ventricle
4. ATP channel may be a trigger rather than the end-effector of preconditioning's anti-infarct effect
5. The protective effect of diazoxide is blocked by anti-oxidants
6. ATP channel for cardiac protection against ischemic injury is dependent on PKC activity
7. ATP channels as effectors of human myocardial preconditioning
8. Diabetes and cardiovascular risk factors
9. Preventing and arresting coronary atherosclerosis
10. Role of diabetes in cardiac disease: Conclusion from population studies
11. Diabetes and the survival and recovery of the anoxic myocardium
12. Effects of ischemia on rat myocardial function and metabolism in diabetes
13. 2+ metabolism
14. Effects of ginkgo biloba extract and preconditioning on diabetic rat myocardium
15. Streptozotocin-induced non-insulin-dependent diabetes protects hearts from infarction
16. Oral sulphonylurea hypoglycaemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited
17. Metabolic factors in myocardial failure
18. Cellular uncoupling during ischemia in hypertrophied and failing rabbit ventricular myocardium. Effects of preconditioning
19. Preconditioning the human myocardium by simulated ischemia: Studies on the early and delayed protection
20. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
21. Arrythmias and mortality in congestive cardiac failure
22. Regulation of energy substrate metabolism in the diabetic heart
23. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to adverse prognosis
24. The diabetic heart is more sensitive to ischemic injury
25. Controversies on the sensitivity of the diabetic heart to ischemic injury: The sensitivity of the diabetic heart to ischemic injury is decreased
26. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts
27. Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection?
28. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: A possible mechanism of cardioprotection
29. ATP-sensitive potassium channels are altered in ventricular myocytes from diabetic rats
30. Ischemic preconditioning does not protect hypertrophied myocardium against ischemia
31. Preconditioning during ischemia: Basic mechanism and potential clinical applications
32. Increased PKC activity and expression of calcium sensitive isoforms in the failing human heart
33. Three different potassium channels in human atrium: Contribution to the basal potassium conductance
34. Differences between outward currents of human atrial and subepicardial ventricular myocytes